Entering text into the input field will update the search result below

(BOB.V, DNDN, DEPO, DMRC) Stock Report from Stock-PR.com

May 21, 2011 9:17 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Stock-PR Reporting


FREE Daily Stock Alerts From Stock-PR.com


http://pennyomega.com/img/bob.jpg Global Hunter Corp. (BOB.V)

Global Hunter's La Corona de Cobre project is over 18,000 hectares of land located in the Coast Range of the Andean Cordillera, Chile, an area often referred to as the Chilean Iron Belt. The property is on the Pan American Highway, 70-kilometres north of the port city La Serena. The property is located at the southern end of the Atacama Fault Zone, a north-northeast regional feature that stretches for over 1,000 kilometers and hosts several large copper deposits in Chile including Phelps Dodge's Candelaria (400 million tons grading 0.95% copper and 0.2% gold) and Anglo-American's Manto Verde (100 million tones averaging 0.80% copper) deposits.

Copper is easily stretched, molded, and shaped; is resistant to corrosion; and conducts heat and electricity efficiently. Copper is used for water pipes and central heating systems (tanks and pipes). This is because it doesn't corrode and its ductility makes it easy to shape and install. It also protects against the growth of unwanted, pathogenic bacteria such as legionella, which thrive in stagnant water storage units.

With the Company being fully funded, they feel it is a beneficial time to update shareholders on its recent corporate development. In addition to company's plan on advancing the existing project, Las Posadas, as described in detail below, Global Hunter is looking forward to the upcoming exploration program on the results from the surface sampling program.


To follow-up on the mapping and recent sampling of several of the additional shear zones on the property, the Company is currently finalizing negotiations for a drilling contract and is expecting to commence drilling in May. The initial drill program will be comprised of 7-10 holes totaling approximately 2,500 to 3,500 metres designed to test the three highest priority targets identified through detailed mapping and recent surface sampling. Ongoing detailed geophysics, mapping, trenching and sampling will be conducted on the secondary targets and along strike of primary targets in order to help pinpoint areas for additional drilling. Contingent on the success of the initial drill campaign and the corresponding surface programs, the Company plans to continue with a second phase of definition drilling.

Global Hunter Corp. engages in the acquisition, exploration, and development of mineral properties in Canada and Chile. It primarily explores for gold, copper, and base and precious metals. The company was founded in 1988 and is headquartered in Vancouver, Canada.

For more information about Global Hunter Corp please visit


Dendreon Corp. (Nasdaq:DNDN) announced that management will present at the following conferences; ThinkEquity Annual Healthcare Conference in New York City, NY on May 25, 2011 at 1:00 p.m. ET. Goldman Sachs Annual Global Healthcare Conference in Rancho Palos Verdes, CA on June 7, 2011 at 2:00 p.m. PT. The presentations will be webcast live and available for replay from Dendreon's website,
www.dendreon.com. If you are unable to listen to the live webcasts, they will be archived on the site following the presentation. To access the replay, go to the Investor Relations section of the website.

Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients.


DepoMed Inc. (Nasdaq:DEPO) announced that it has received a Paragraph IV certification notice from Sun Pharmaceutical Industries advising Depomed that Sun has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market a generic version of Glumetza® (metformin hydrochloride extended release tablets), 500 mg and 1000 mg strengths. Sun`s certification notice alleges that the five U.S. Patents listed in the FDA Orange Book for Glumetza, with expiration dates ranging from 2016 to 2025, will not be infringed by Sun`s proposed product, or are invalid and/or are unenforceable.

Depomed, Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States. Depomed, Inc. was founded in 1995 and is based in Menlo Park, California.


Digimarc Corporation (Nasdaq:DMRC) has been invited to present at the GARP Research & Securities Investor Conference. The conference will be held at the Renaissance Harborplace Hotel in Baltimore, Maryland on May 24-26, 2011. Michael McConnell, Digimarc's Chief Financial Officer, is scheduled to present on Thursday, May 26 at 1:00 p.m. Eastern time, with one-on-one meetings held throughout the day. He will discuss the company's financial performance and growth strategy.

Digimarc Corporation provides media identification and management solutions to commercial entities and government customers in the United States and internationally. The company is based in Beaverton, Oregon.



Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.

Sign Up For Free Stock Alerts At http://stock-pr.com/signup


Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.